 Charles Hoeffer
Concepts (311)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long-Term Potentiation | 10 | 2017 | 196 | 1.920 |
Why?
| | Muscle Proteins | 4 | 2022 | 220 | 1.850 |
Why?
| | Intracellular Signaling Peptides and Proteins | 5 | 2015 | 441 | 1.540 |
Why?
| | Neuronal Plasticity | 12 | 2017 | 279 | 1.310 |
Why?
| | Protein Biosynthesis | 5 | 2021 | 410 | 1.250 |
Why?
| | Down Syndrome | 4 | 2022 | 478 | 1.110 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2020 | 432 | 1.100 |
Why?
| | Hippocampus | 11 | 2017 | 873 | 1.070 |
Why?
| | Memory | 6 | 2021 | 266 | 1.020 |
Why?
| | Behavior, Animal | 9 | 2023 | 505 | 1.010 |
Why?
| | Alzheimer Disease | 4 | 2022 | 514 | 0.920 |
Why?
| | Neurons | 10 | 2024 | 1494 | 0.910 |
Why?
| | Calcium-Binding Proteins | 3 | 2022 | 213 | 0.890 |
Why?
| | Epistasis, Genetic | 2 | 2023 | 70 | 0.820 |
Why?
| | Brain | 4 | 2020 | 2673 | 0.800 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2023 | 68 | 0.790 |
Why?
| | Chronobiology Disorders | 1 | 2022 | 13 | 0.780 |
Why?
| | DNA-Binding Proteins | 5 | 2023 | 1445 | 0.740 |
Why?
| | Spatial Memory | 1 | 2020 | 24 | 0.700 |
Why?
| | Dendritic Spines | 2 | 2021 | 64 | 0.680 |
Why?
| | Extinction, Psychological | 1 | 2020 | 91 | 0.650 |
Why?
| | Interleukin-17 | 2 | 2017 | 108 | 0.640 |
Why?
| | Synapses | 9 | 2017 | 396 | 0.640 |
Why?
| | Aging | 2 | 2022 | 1778 | 0.620 |
Why?
| | Mice | 32 | 2024 | 16961 | 0.620 |
Why?
| | Signal Transduction | 11 | 2016 | 4931 | 0.610 |
Why?
| | TOR Serine-Threonine Kinases | 6 | 2014 | 398 | 0.610 |
Why?
| | Animals | 41 | 2024 | 35391 | 0.590 |
Why?
| | Mice, Knockout | 16 | 2024 | 2881 | 0.580 |
Why?
| | Tauopathies | 2 | 2016 | 9 | 0.550 |
Why?
| | Anxiety | 5 | 2023 | 972 | 0.550 |
Why?
| | Transcriptome | 1 | 2023 | 876 | 0.540 |
Why?
| | Eukaryotic Initiation Factor-4E | 2 | 2021 | 27 | 0.540 |
Why?
| | Basolateral Nuclear Complex | 1 | 2017 | 14 | 0.540 |
Why?
| | Memory, Long-Term | 2 | 2020 | 13 | 0.540 |
Why?
| | Memory Consolidation | 1 | 2017 | 11 | 0.540 |
Why?
| | Sleep | 2 | 2024 | 687 | 0.530 |
Why?
| | Fragile X Syndrome | 3 | 2012 | 81 | 0.520 |
Why?
| | Nerve Degeneration | 1 | 2015 | 47 | 0.490 |
Why?
| | Genome-Wide Association Study | 4 | 2023 | 1326 | 0.480 |
Why?
| | Autism Spectrum Disorder | 2 | 2017 | 388 | 0.460 |
Why?
| | Protein Synthesis Inhibitors | 2 | 2012 | 44 | 0.450 |
Why?
| | Up-Regulation | 2 | 2021 | 840 | 0.450 |
Why?
| | Gene Expression Regulation | 6 | 2017 | 2542 | 0.450 |
Why?
| | Mice, Inbred C57BL | 12 | 2024 | 5455 | 0.430 |
Why?
| | Sensory Gating | 2 | 2013 | 45 | 0.430 |
Why?
| | Fluoxetine | 1 | 2013 | 52 | 0.410 |
Why?
| | GABAergic Neurons | 1 | 2013 | 29 | 0.410 |
Why?
| | Eukaryotic Initiation Factor-4F | 1 | 2012 | 2 | 0.410 |
Why?
| | Gene Expression | 1 | 2017 | 1465 | 0.400 |
Why?
| | Mice, Transgenic | 8 | 2018 | 2128 | 0.390 |
Why?
| | Disease Models, Animal | 11 | 2023 | 4078 | 0.390 |
Why?
| | Protein Phosphatase 1 | 2 | 2013 | 33 | 0.390 |
Why?
| | Interneurons | 1 | 2013 | 117 | 0.390 |
Why?
| | Mental Disorders | 1 | 2020 | 1034 | 0.390 |
Why?
| | Mitochondria | 2 | 2015 | 876 | 0.370 |
Why?
| | Eukaryotic Initiation Factor-4G | 1 | 2011 | 5 | 0.360 |
Why?
| | Corticosterone | 1 | 2012 | 220 | 0.360 |
Why?
| | tau Proteins | 3 | 2016 | 76 | 0.340 |
Why?
| | Wakefulness | 2 | 2024 | 120 | 0.340 |
Why?
| | eIF-2 Kinase | 2 | 2024 | 30 | 0.340 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2012 | 399 | 0.330 |
Why?
| | Astrocytes | 2 | 2024 | 195 | 0.320 |
Why?
| | Raptors | 1 | 2008 | 2 | 0.310 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2008 | 8 | 0.310 |
Why?
| | Motor Activity | 3 | 2022 | 676 | 0.310 |
Why?
| | Feces | 1 | 2012 | 442 | 0.310 |
Why?
| | Circadian Rhythm | 1 | 2012 | 413 | 0.300 |
Why?
| | Phosphorylation | 9 | 2016 | 1713 | 0.290 |
Why?
| | Maze Learning | 5 | 2014 | 104 | 0.290 |
Why?
| | Fragile X Mental Retardation Protein | 4 | 2012 | 55 | 0.280 |
Why?
| | Protein Isoforms | 2 | 2020 | 388 | 0.280 |
Why?
| | Receptors, Metabotropic Glutamate | 4 | 2014 | 41 | 0.280 |
Why?
| | Protein Kinases | 2 | 2008 | 318 | 0.280 |
Why?
| | Memory Disorders | 3 | 2015 | 168 | 0.270 |
Why?
| | Fear | 3 | 2008 | 354 | 0.270 |
Why?
| | Nervous System Diseases | 1 | 2009 | 251 | 0.270 |
Why?
| | RNA, Messenger | 4 | 2017 | 2708 | 0.260 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2023 | 2060 | 0.260 |
Why?
| | Analysis of Variance | 4 | 2017 | 1293 | 0.250 |
Why?
| | Phenotype | 5 | 2023 | 3075 | 0.240 |
Why?
| | Male | 19 | 2024 | 63670 | 0.230 |
Why?
| | Hydrazones | 2 | 2017 | 26 | 0.230 |
Why?
| | Anti-Anxiety Agents | 2 | 2023 | 45 | 0.230 |
Why?
| | Drosophila melanogaster | 2 | 2003 | 210 | 0.230 |
Why?
| | Thiazoles | 2 | 2017 | 117 | 0.230 |
Why?
| | In Vitro Techniques | 7 | 2014 | 1087 | 0.230 |
Why?
| | Mutation | 3 | 2016 | 3717 | 0.220 |
Why?
| | Cyclic GMP-Dependent Protein Kinase Type II | 2 | 2014 | 2 | 0.220 |
Why?
| | Coculture Techniques | 1 | 2024 | 223 | 0.210 |
Why?
| | Diazepam | 1 | 2023 | 34 | 0.210 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 3 | 2013 | 141 | 0.210 |
Why?
| | Gliosis | 1 | 2023 | 28 | 0.210 |
Why?
| | RNA, Double-Stranded | 1 | 2023 | 47 | 0.210 |
Why?
| | Rats, Sprague-Dawley | 4 | 2021 | 2395 | 0.200 |
Why?
| | Vesicular Transport Proteins | 1 | 2003 | 84 | 0.200 |
Why?
| | Suprachiasmatic Nucleus | 1 | 2022 | 15 | 0.200 |
Why?
| | Long-Term Synaptic Depression | 3 | 2014 | 56 | 0.190 |
Why?
| | Sleep Deprivation | 1 | 2024 | 171 | 0.190 |
Why?
| | Neural Inhibition | 2 | 2017 | 158 | 0.190 |
Why?
| | Multifactorial Inheritance | 1 | 2023 | 150 | 0.190 |
Why?
| | Prefrontal Cortex | 2 | 2017 | 305 | 0.190 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 221 | 0.180 |
Why?
| | Cerebral Cortex | 2 | 2016 | 439 | 0.180 |
Why?
| | Nerve Tissue Proteins | 3 | 2024 | 569 | 0.180 |
Why?
| | Gene Regulatory Networks | 1 | 2023 | 281 | 0.180 |
Why?
| | Spatial Behavior | 1 | 2020 | 27 | 0.180 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 113 | 0.180 |
Why?
| | Motor Neurons | 1 | 2023 | 234 | 0.180 |
Why?
| | Spinal Cord | 1 | 2023 | 353 | 0.170 |
Why?
| | Calcineurin | 2 | 2013 | 98 | 0.170 |
Why?
| | Receptors, Nicotinic | 2 | 2020 | 327 | 0.170 |
Why?
| | Cell Nucleus | 1 | 2003 | 584 | 0.170 |
Why?
| | Anxiety Disorders | 1 | 2023 | 353 | 0.170 |
Why?
| | Behavior, Addictive | 1 | 2020 | 81 | 0.160 |
Why?
| | Synaptic Transmission | 2 | 2014 | 272 | 0.160 |
Why?
| | Rats | 4 | 2021 | 5483 | 0.160 |
Why?
| | Artificial Intelligence | 1 | 2022 | 245 | 0.160 |
Why?
| | Genetic Markers | 1 | 2020 | 336 | 0.160 |
Why?
| | Amygdala | 2 | 2011 | 199 | 0.150 |
Why?
| | Memory, Short-Term | 2 | 2014 | 265 | 0.150 |
Why?
| | Electrocorticography | 1 | 2018 | 15 | 0.140 |
Why?
| | Conditioning, Classical | 2 | 2017 | 117 | 0.140 |
Why?
| | Brain Waves | 1 | 2018 | 31 | 0.140 |
Why?
| | Models, Biological | 3 | 2009 | 1724 | 0.140 |
Why?
| | Polyribosomes | 1 | 2017 | 22 | 0.140 |
Why?
| | Neurofibrillary Tangles | 1 | 2016 | 13 | 0.130 |
Why?
| | Models, Animal | 2 | 2017 | 378 | 0.130 |
Why?
| | Cell Differentiation | 1 | 2024 | 1891 | 0.130 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2017 | 146 | 0.130 |
Why?
| | Pyramidal Cells | 1 | 2017 | 69 | 0.130 |
Why?
| | Association Learning | 1 | 2017 | 68 | 0.130 |
Why?
| | CA1 Region, Hippocampal | 2 | 2014 | 51 | 0.130 |
Why?
| | Transcription Factors | 2 | 2022 | 1647 | 0.130 |
Why?
| | Dynamins | 1 | 2015 | 35 | 0.120 |
Why?
| | Female | 9 | 2023 | 68734 | 0.120 |
Why?
| | Sex Characteristics | 1 | 2020 | 736 | 0.120 |
Why?
| | Nicotinic Agonists | 1 | 2017 | 120 | 0.120 |
Why?
| | Th17 Cells | 1 | 2016 | 84 | 0.120 |
Why?
| | Haloperidol | 2 | 2014 | 32 | 0.120 |
Why?
| | Antipsychotic Agents | 2 | 2014 | 195 | 0.120 |
Why?
| | Alcoholism | 1 | 2021 | 765 | 0.120 |
Why?
| | Maternal-Fetal Exchange | 1 | 2016 | 162 | 0.120 |
Why?
| | Pyridines | 3 | 2013 | 478 | 0.110 |
Why?
| | Electric Stimulation | 3 | 2014 | 267 | 0.110 |
Why?
| | Humans | 17 | 2024 | 129626 | 0.110 |
Why?
| | Neuroimaging | 1 | 2017 | 279 | 0.110 |
Why?
| | Antibodies | 1 | 2016 | 398 | 0.110 |
Why?
| | Nicotine | 1 | 2017 | 302 | 0.110 |
Why?
| | Social Behavior | 1 | 2017 | 288 | 0.110 |
Why?
| | Cell Count | 2 | 2013 | 312 | 0.110 |
Why?
| | GABA-A Receptor Agonists | 1 | 2013 | 17 | 0.110 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2011 | 119 | 0.100 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2014 | 168 | 0.100 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2013 | 110 | 0.100 |
Why?
| | Sterols | 1 | 2012 | 18 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1500 | 0.100 |
Why?
| | Nitro Compounds | 1 | 2012 | 6 | 0.100 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 155 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 740 | 0.100 |
Why?
| | Photoperiod | 1 | 2012 | 46 | 0.100 |
Why?
| | Gene Deletion | 1 | 2013 | 382 | 0.100 |
Why?
| | Reaction Time | 1 | 2013 | 417 | 0.090 |
Why?
| | Motor Skills | 1 | 2012 | 92 | 0.090 |
Why?
| | Ribosomal Protein S6 | 1 | 2011 | 16 | 0.090 |
Why?
| | Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2011 | 9 | 0.090 |
Why?
| | Amyloid beta-Peptides | 2 | 2011 | 211 | 0.090 |
Why?
| | Sirolimus | 2 | 2011 | 270 | 0.090 |
Why?
| | Dopamine | 1 | 2014 | 285 | 0.090 |
Why?
| | Primary Cell Culture | 1 | 2012 | 164 | 0.090 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2008 | 37 | 0.090 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2014 | 185 | 0.090 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1687 | 0.090 |
Why?
| | Oxidants | 1 | 2011 | 109 | 0.090 |
Why?
| | Genotype | 2 | 2014 | 1833 | 0.090 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 133 | 0.090 |
Why?
| | Superoxides | 1 | 2011 | 201 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2016 | 574 | 0.080 |
Why?
| | Oxidative Stress | 1 | 2015 | 1266 | 0.080 |
Why?
| | Enzyme Inhibitors | 2 | 2011 | 827 | 0.080 |
Why?
| | Peptide Elongation Factor 1 | 1 | 2008 | 8 | 0.070 |
Why?
| | Exploratory Behavior | 1 | 2008 | 88 | 0.070 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2008 | 21 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2014 | 1125 | 0.070 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2007 | 132 | 0.070 |
Why?
| | Pregnancy | 2 | 2017 | 6417 | 0.070 |
Why?
| | Activating Transcription Factor 4 | 1 | 2007 | 20 | 0.070 |
Why?
| | In Situ Hybridization | 1 | 2007 | 297 | 0.070 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2007 | 26 | 0.070 |
Why?
| | Space Perception | 1 | 2008 | 80 | 0.070 |
Why?
| | Eukaryotic Initiation Factors | 2 | 2021 | 10 | 0.070 |
Why?
| | Granulomatous Disease, Chronic | 1 | 2006 | 53 | 0.060 |
Why?
| | Neuromuscular Junction | 2 | 2003 | 58 | 0.060 |
Why?
| | Sex Factors | 1 | 2012 | 1970 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2024 | 4084 | 0.060 |
Why?
| | Infant, Newborn | 1 | 2017 | 5756 | 0.060 |
Why?
| | Larva | 2 | 2003 | 215 | 0.060 |
Why?
| | Cohort Studies | 1 | 2015 | 5426 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2003 | 312 | 0.060 |
Why?
| | Protein Binding | 1 | 2011 | 2124 | 0.060 |
Why?
| | Time Factors | 2 | 2012 | 6555 | 0.060 |
Why?
| | Sleep, REM | 1 | 2024 | 34 | 0.060 |
Why?
| | Electrodes | 1 | 2024 | 105 | 0.050 |
Why?
| | Carrier Proteins | 2 | 2010 | 745 | 0.050 |
Why?
| | N-Ethylmaleimide-Sensitive Proteins | 1 | 2003 | 5 | 0.050 |
Why?
| | Body Temperature | 1 | 2024 | 212 | 0.050 |
Why?
| | Calcium-Transporting ATPases | 1 | 2003 | 40 | 0.050 |
Why?
| | Learning | 1 | 2008 | 407 | 0.050 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2003 | 37 | 0.050 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 2003 | 37 | 0.050 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2003 | 40 | 0.050 |
Why?
| | Blood-Brain Barrier | 1 | 2024 | 131 | 0.050 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2003 | 113 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 131 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2023 | 406 | 0.050 |
Why?
| | Paralysis | 1 | 2003 | 69 | 0.050 |
Why?
| | Methoxyhydroxyphenylglycol | 2 | 2014 | 14 | 0.050 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 235 | 0.050 |
Why?
| | Species Specificity | 1 | 2023 | 574 | 0.050 |
Why?
| | Adult | 2 | 2017 | 35599 | 0.050 |
Why?
| | Transcription Factor AP-1 | 1 | 2002 | 88 | 0.050 |
Why?
| | Electroencephalography | 1 | 2024 | 409 | 0.050 |
Why?
| | Drosophila Proteins | 1 | 2003 | 185 | 0.050 |
Why?
| | Psychopathology | 1 | 2021 | 50 | 0.050 |
Why?
| | Central Nervous System | 1 | 2003 | 255 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2024 | 877 | 0.040 |
Why?
| | Temperature | 1 | 2003 | 637 | 0.040 |
Why?
| | Receptors, AMPA | 2 | 2012 | 140 | 0.040 |
Why?
| | Bombyx | 1 | 2000 | 6 | 0.040 |
Why?
| | Apolipoproteins | 1 | 2000 | 38 | 0.040 |
Why?
| | Seizures | 1 | 2003 | 401 | 0.040 |
Why?
| | Ultrasonography | 1 | 2003 | 712 | 0.040 |
Why?
| | NADPH Oxidase 2 | 2 | 2011 | 38 | 0.040 |
Why?
| | NADPH Oxidases | 2 | 2011 | 108 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 495 | 0.040 |
Why?
| | Child, Preschool | 1 | 2012 | 10490 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2002 | 824 | 0.030 |
Why?
| | Prepulse Inhibition | 1 | 2017 | 9 | 0.030 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2017 | 46 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2010 | 361 | 0.030 |
Why?
| | Reflex, Startle | 1 | 2017 | 67 | 0.030 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 98 | 0.030 |
Why?
| | Membrane Glycoproteins | 2 | 2011 | 477 | 0.030 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2016 | 12 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2017 | 376 | 0.030 |
Why?
| | Antibodies, Blocking | 1 | 2016 | 33 | 0.030 |
Why?
| | Receptors, Retinoic Acid | 1 | 2016 | 51 | 0.030 |
Why?
| | CRISPR-Cas Systems | 1 | 2017 | 109 | 0.030 |
Why?
| | Behavioral Symptoms | 1 | 2016 | 42 | 0.030 |
Why?
| | Young Adult | 1 | 2012 | 12455 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2021 | 765 | 0.030 |
Why?
| | Tobacco Use Disorder | 1 | 2017 | 236 | 0.030 |
Why?
| | Electrical Synapses | 1 | 2014 | 11 | 0.030 |
Why?
| | Biophysical Phenomena | 1 | 2014 | 64 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2014 | 119 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2012 | 16 | 0.030 |
Why?
| | Post-Synaptic Density | 1 | 2012 | 12 | 0.030 |
Why?
| | Adolescent | 1 | 2012 | 20412 | 0.030 |
Why?
| | Microtubule-Associated Proteins | 1 | 2014 | 192 | 0.030 |
Why?
| | Aged | 1 | 2012 | 22061 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2012 | 90 | 0.020 |
Why?
| | Schizophrenia | 1 | 2017 | 431 | 0.020 |
Why?
| | Child | 1 | 2012 | 20884 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2011 | 53 | 0.020 |
Why?
| | Emetine | 1 | 2011 | 6 | 0.020 |
Why?
| | Bicuculline | 1 | 2011 | 21 | 0.020 |
Why?
| | rap GTP-Binding Proteins | 1 | 2011 | 6 | 0.020 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2011 | 17 | 0.020 |
Why?
| | Onium Compounds | 1 | 2011 | 11 | 0.020 |
Why?
| | Ubiquinone | 1 | 2011 | 28 | 0.020 |
Why?
| | Electrophysiological Phenomena | 1 | 2011 | 54 | 0.020 |
Why?
| | Flavonoids | 1 | 2011 | 77 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2011 | 100 | 0.020 |
Why?
| | Biphenyl Compounds | 1 | 2011 | 60 | 0.020 |
Why?
| | Isoproterenol | 1 | 2011 | 116 | 0.020 |
Why?
| | Biophysics | 1 | 2011 | 68 | 0.020 |
Why?
| | Middle Aged | 1 | 2012 | 31136 | 0.020 |
Why?
| | Organophosphorus Compounds | 1 | 2011 | 78 | 0.020 |
Why?
| | Adrenergic beta-Agonists | 1 | 2011 | 133 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4404 | 0.020 |
Why?
| | Eukaryotic Initiation Factor-4A | 1 | 2010 | 4 | 0.020 |
Why?
| | Patch-Clamp Techniques | 1 | 2011 | 277 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2010 | 24 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2010 | 157 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2011 | 813 | 0.020 |
Why?
| | Serine | 1 | 2010 | 138 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 342 | 0.020 |
Why?
| | RNA 5' Terminal Oligopyrimidine Sequence | 1 | 2008 | 1 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 593 | 0.020 |
Why?
| | Autistic Disorder | 1 | 2010 | 189 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 558 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2010 | 335 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 169 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2011 | 2011 | 0.020 |
Why?
| | Peptide Fragments | 1 | 2010 | 693 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 2010 | 584 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 858 | 0.020 |
Why?
| | Conditioning, Operant | 1 | 2006 | 104 | 0.020 |
Why?
| | Taste | 1 | 2008 | 216 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2010 | 505 | 0.020 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 211 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2002 | 53 | 0.010 |
Why?
| | Electrophysiology | 1 | 2002 | 210 | 0.010 |
Why?
| | Dimerization | 1 | 2002 | 192 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 161 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2002 | 175 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2002 | 238 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2000 | 270 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2002 | 1207 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2000 | 2057 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2000 | 2835 | 0.010 |
Why?
|
|
Hoeffer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|